AURO-DARUNAVIR

auro pharma inc🇨🇦 Health Canada

Approval Id: 5cf44d0dbf99b670
Drug Approval Canada Name: AURO-DARUNAVIR
Product Name: AURO-DARUNAVIR
Status: Marketed
Status Date: 2020-03-18
Original Market Date: 2020-03-18
Din: 02486148
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 08:18.08.08
Atc Original: J05AE10 DARUNAVIR
Atc Name: j 05 ae 10
Aig Number: 0151656006
Company Name: auro pharma inc
Company Address: 3700 Steeles Avenue West, Suite 402, Woodbridge, Ontario, Canada, L4L 8K8

DARUNAVIR (DARUNAVIR PROPYLENE GLYCOLATE)

800 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

5cf44d0dbf99b670

Type

Standard